Draft Genome Sequences of Two Extensively Drug-Resistant Strains of Acinetobacter baumannii Isolated from Clinical Samples in Pakistan

Sara Lomonaco; Matthew A Crawford; Christine Lascols; Debra J Fisher; Kevin Anderson; David R Hodge; Segaran P Pillai; Stephen A Morse; Erum Khan; Molly A Hughes; Marc W Allard; Shashi K Sharma

doi:10.1128/MRA.00026-20

Draft Genome Sequences of Two Extensively Drug-Resistant Strains of Acinetobacter baumannii Isolated from Clinical Samples in Pakistan

Microbiol Resour Announc. 2020 May 14;9(20):e00026-20. doi: 10.1128/MRA.00026-20.

Authors

Affiliations

¹ Division of Microbiology, Office of Regulatory Science, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA sara.lomonaco@fda.hhs.gov.
² Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
³ National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
⁴ IHRC, Inc., Atlanta, Georgia, USA.
⁵ Science and Technology Directorate, U.S. Department of Homeland Security, Washington, DC, USA.
⁶ Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
⁷ Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.
⁸ Division of Microbiology, Office of Regulatory Science, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA.

Abstract

Infections in immunocompromised patients that are caused by extensively drug-resistant (XDR) Acinetobacter baumannii strains have been increasingly reported worldwide. In particular, carbapenem-resistant A. baumannii strains are a prominent cause of health care-associated infections. Here, we report draft genome assemblies for two clinical XDR A. baumannii isolates obtained from hospitalized patients in Pakistan.

Grants and funding

R21 AI139947/AI/NIAID NIH HHS/United States